F
F. Montorsi
Researcher at Vita-Salute San Raffaele University
Publications - 200
Citations - 3745
F. Montorsi is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Prostate cancer & Prostatectomy. The author has an hindex of 28, co-authored 196 publications receiving 3312 citations.
Papers
More filters
Journal ArticleDOI
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
Marco Bianchi,Maxine Sun,Claudio Jeldres,Shahrokh F. Shariat,Quoc-Dien Trinh,Quoc-Dien Trinh,Alberto Briganti,Z. Tian,Jan Schmitges,Markus Graefen,Paul Perrotte,Mani Menon,F. Montorsi,Pierre I. Karakiewicz +13 more
TL;DR: The proportion of patients with multiple metastatic sites is higher in young patients, and the rates of bone and brain metastases are nonnegligible in mRCC patients.
Journal ArticleDOI
Positive Surgical Margins in Radical Prostatectomy: Outlining the Problem and Its Long-Term Consequences
Ofer Yossepowitch,Anders Bjartell,James A. Eastham,Markus Graefen,Bertrand Guillonneau,Pierre I. Karakiewicz,Rodolfo Montironi,F. Montorsi +7 more
TL;DR: Level-1 evidence indicates that adjuvant radiotherapy in men with PSM reduces BCR rates and clinical progression and possibly improves overall survival (OS), and an evidence-based approach to assist clinicians in counseling patients with a PSM is provided.
Journal ArticleDOI
Erectile dysfunction and coronary artery disease prediction: Evidence-based guidance and consensus
Graham Jackson,N. Boon,Ian Eardley,Mike Kirby,John Dean,Geoffrey Hackett,Piero Montorsi,F. Montorsi,Charalambos Vlachopoulos,Robert A. Kloner,Ira D. Sharlip,Martin Miner +11 more
TL;DR: Clinical evidence supports the use of phosphodiesterase 5 (PDE5) inhibitors as first‐line therapy in men with CAD and comorbid ED and those with diabetes and ED (Level 1, Grade A).
Journal ArticleDOI
Safety of Sildenafil Citrate: Review of 67 Double-Blind Placebo-Controlled Trials and the Postmarketing Safety Database
TL;DR: To review special safety topics associated with sildenafil and to document the tolerability of 50‐ and 100‐mg doses, overall and by age, in men with erectile dysfunction (ED).
Journal ArticleDOI
Women's sexual dysfunction: a pathophysiological review.
Andrea Salonia,Ricardo Munarriz,Richard Naspro,Rossella E. Nappi,Alberto Briganti,R. Chionna,F. Federghini,Vincenzo Mirone,Patrizio Rigatti,Irwin Goldstein,F. Montorsi +10 more
TL;DR: This work presents a meta-analyses of the prophylactic and statistical literature Reviews of Urology and Gynaecology using a Comparative Urology/Gynaecological Assessment System (CAS) and shows clear trends in prognosis and survival rates.